As one of the main components of the tumor microenvironment (TME), the so-called cancer-associated fibroblasts (CAF) have proven to be a pivotal player in the progression of several solid tumors. CAF are transformed cells that can have origin in multiple cellular types, and are presented as different subsets showing phenotypic heterogeneity and functional diversity. CAF populations extracted from human cancer cells of many types have been shown to possess the ability to influence the known signs of cancer. So far, CAF have been shown to promote tumor cell invasion and migration, angiogenesis, proliferation, adhesion, immunosuppression, treatment resistance and worsen patient’s prognosis. Within the TME, CAF also can be a barrier against drugs and immune responses from the body, contributing to regulate malignant progression. Because of its relevance in the disease mechanisms, efforts should be applied towards the better understanding of CAF features and functions. In that sense, this Methods Collection has the intent to publish novel or improved methods related to CAF cells establishment, culturing, characterization, interactions with tumor cells and other cells from TME, matrix remodeling, and CAF-targeting cancer treatment.
0 Views
•
Cited by 3
•
2021
•
Hiroki Kobayashi1,2,3,4, Krystyna A. Gieniec1,2, Jia Q. Ng1,2, Jarrad Goyne1,2, Tamsin R. M. Lannagan1,2, Elaine M. Thomas1,2, Georgette Radford1,2, Tongtong Wang1,2, Nobumi Suzuki1,2,5, Mari Ichinose1,2, Josephine A. Wright2, Laura Vrbanac1,2, Alastair D. Burt6, Masahide Takahashi3,4,7, Atsushi Enomoto3, Daniel L. Worthley2, Susan L. Woods1,2
1Adelaide Medical School, University of Adelaide, 2South Australian Health and Medical Research Institute (SAHMRI), 3Department of Pathology, Nagoya University Graduate School of Medicine, 4Division of Molecular Pathology, Center for Neurological Disease and Cancer, Nagoya University Graduate School of Medicine, 5Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 6Translational and Clinical Research Institute, Newcastle University, 7International Center for Cell and Gene Therapy, Fujita Health University
Isolation of primary cancer-associated fibroblasts from a syngeneic murine breast cancer: a model to study targeted nanoparticles
Fabio Corsi*1,
Marta Truffi2,
Marta Sevieri1,
Leopoldo Sitia1,
Arianna Bonizzi1,
Serena Mazzucchelli*1
1University of Milan,
2IRCCS ICS Maugeri